Harmony Biosciences Holdings, Inc. Stock Analysis & AI Score
Harmony Biosciences Holdings, Inc. (HRMY) has an ST Score of 57.0 (B-), driven by its Profitability (A+) and held back by its Financial Strength (D). Analysts rate it Buy with a $48.50 price target (+17.8% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Harmony Biosciences Holdings, Inc. (HRMY) has an ST Score of 57.0 (B-), driven by its Profitability (A+) and held back by its Financial Strength (D). Analysts rate it Buy with a $48.50 price target (+17.8% upside).
- Strongest
- ProfitabilityA+
- Weakest
- Financial StrengthD
All factor grades
- ProfitabilityA+
- MomentumA
- GrowthB
- ForecastB-
- ValuationD+
- Financial StrengthD
- Piotroski5/9
Contact
HRMY stock: frequently asked questions
What is HRMY's ST Score?
Harmony Biosciences Holdings, Inc. (HRMY) has an ST Score of 57.0 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is HRMY a buy, hold, or sell?
Analysts rate HRMY a Buy, with a price target of $48.50 (+17.8% vs the current price). Our ST Score grades it B- (57.0/100). The ST Score is a data-driven signal, not a recommendation.
What are HRMY's factor grades?
Valuation D+, Profitability A+, Financial Strength D, Momentum A, Growth B, Forecast B-.
What is HRMY's valuation grade?
Harmony Biosciences Holdings, Inc. (HRMY) earns a valuation grade of D+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is HRMY's growth grade?
Harmony Biosciences Holdings, Inc. (HRMY) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is HRMY's profitability grade?
Harmony Biosciences Holdings, Inc. (HRMY) earns a profitability grade of A+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is HRMY's financial strength grade?
Harmony Biosciences Holdings, Inc. (HRMY) earns a financial strength grade of D, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for HRMY?
The average analyst price target for Harmony Biosciences Holdings, Inc. (HRMY) is $48.50 from 13 analysts, which is +17.8% versus the recent price of $41.16.
What is HRMY's Piotroski score?
Harmony Biosciences Holdings, Inc. (HRMY) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.